
Human MAGE C2 336-344, ALKDVEERV
Description
About Human MAGE C2 336-344, ALKDVEERV
The Human Melanoma-associated antigen (MAGE) C2 Peptide (IEDB: 237634) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Melanoma-associated antigen (MAGE) Peptide, H-ALKDVEERV-OH (Uniprot: Q9UBF1 aa: 336-344) from JPT is produced under strict quality control and quality management.
Human MAGE C2 336-344, ALKDVEERV - Specifications
- Peptide sequence: H-ALKDVEERV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human MAGE C2 336-344, ALKDVEERV
References:
Read References with JPT’s Antigen Peptides
Human MAGE C2 336-344, ALKDVEERV has been described in:
Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases., Cancer Res, 2011 (PMID: 21216894)
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer., J Immunother Cancer, 2019 (PMID: 31727154)
Documentation
Documentation for Human MAGE C2 336-344, ALKDVEERV
Properties
Properties of Human MAGE C2 336-344, ALKDVEERV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Melanoma-associated antigen (MAGE) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human MAGE C2 336-344, ALKDVEERV
Information | Values |
---|---|
Sequence: | H-ALKDVEERV-OH |
Specifications: | 9mer peptide as TFA salt |